316 related articles for article (PubMed ID: 8922768)
1. The reversal of profound mivacurium-induced neuromuscular blockade.
Kao YJ; Le ND
Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
[TBL] [Abstract][Full Text] [Related]
2. Neostigmine but not edrophonium prolongs the action of mivacurium.
Symington MJ; Mirakhur RK; Kumar N
Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
[TBL] [Abstract][Full Text] [Related]
3. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
[TBL] [Abstract][Full Text] [Related]
4. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
[TBL] [Abstract][Full Text] [Related]
5. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium.
Lessard MR; Trépanier CA; Rouillard JF
Can J Anaesth; 1997 Aug; 44(8):836-42. PubMed ID: 9260011
[TBL] [Abstract][Full Text] [Related]
6. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium.
Szenohradszky J; Fogarty D; Kirkegaard-Nielsen H; Brown R; Sharma ML; Fisher DM
Anesthesiology; 2000 Mar; 92(3):708-14. PubMed ID: 10719950
[TBL] [Abstract][Full Text] [Related]
7. Reversal of mivacurium chloride: edrophonium of spontaneous recovery in microscopic laryngeal surgery.
Ting CK; Lin SM; Yang YW; Tsai HJ; Lao HC; Chu YC; Tsai SK
Acta Anaesthesiol Sin; 2001 Dec; 39(4):157-62. PubMed ID: 11840581
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
Devcic A; Munshi CA; Gandhi SK; Kampine JP
Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
[TBL] [Abstract][Full Text] [Related]
9. A comparison of edrophonium and neostigmine for the reversal of mivacurium-induced neuromuscular blockade in sheep.
Clutton RE; Glasby MA
Res Vet Sci; 1998; 64(3):265-6. PubMed ID: 9690616
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
Fleming NW; Lewis BK
Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
[TBL] [Abstract][Full Text] [Related]
12. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
Yang HS; Goudsouzian N; Martyn JA
Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.
Lien CA; Belmont MR; Wray Roth DL; Okamoto M; Abalos A; Savarese JJ
Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936
[TBL] [Abstract][Full Text] [Related]
15. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
[TBL] [Abstract][Full Text] [Related]
16. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion.
Maddineni VR; Mirakhur RK; McCoy EP
Anaesthesia; 1994 Nov; 49(11):946-8. PubMed ID: 7802237
[TBL] [Abstract][Full Text] [Related]
17. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
[TBL] [Abstract][Full Text] [Related]
19. Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block.
Abdulatif M
Br J Anaesth; 1995 Jan; 74(1):20-5. PubMed ID: 7880699
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
